Rockefeller Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4
| Closed | – | – | 3856 |
|
|
2022
Q4 | $0 | Sell |
4
-72
| -95% | – | ﹤0.01% | 4243 |
|
|
2022
Q3 | $0 | Hold |
76
| – | – | ﹤0.01% | 4418 |
|
|
2022
Q2 | $0 | Buy |
76
+1
| +1% | – | ﹤0.01% | 4417 |
|
|
2022
Q1 | $0 | Buy |
75
+2
| +3% | – | ﹤0.01% | 4082 |
|
|
2021
Q4 | $1K | Hold |
73
| – | – | ﹤0.01% | 3703 |
|
|
2021
Q3 | $1K | Buy |
73
+1
| +1% | +$14 | ﹤0.01% | 3628 |
|
|
2021
Q2 | $4K | Buy |
+72
| New | +$4K | ﹤0.01% | 3116 |
|
|
2020
Q2 | – | Sell |
-110
| Closed | -$21K | – | 2705 |
|
|
2020
Q1 | $21K | Hold |
110
| – | – | ﹤0.01% | 1507 |
|
|
2019
Q4 | $37K | Hold |
110
| – | – | ﹤0.01% | 1229 |
|
|
2019
Q3 | $36K | Buy |
+110
| New | +$36K | ﹤0.01% | 1072 |
|